A80 (2E1)
Gender: Female
Smoking habit: Smoker or non-smoker
Pot smoking
51 - 73
BMI : 22.30 - 33.60
Food restrictions : Fast
Clinic stay
- 3 Apr (17:30) to 9 Apr (09:00)
- 17 Apr (17:30) to 23 Apr (09:00)
Participants must be available to stay at our clinic for all of the dates listed above and/or in the notes below. All clinic stays and return visits are mandatory. Times are subject to change.
Medication type
This drug is being developed for the potential treatment of chronic hepatitis C and coronavirus disease 2019 (COVID-19), a respiratory disease caused by a specific type of virus.
Notes
We are looking for males who are 53 to 73 years old with BMI of 22.4 to 33.6 kg/m2 and females who are 51 to 71 years old with BMI of 22.3 to 33.5 kg/m2.
Phase 1 study.
12 hours fasting before medical exam.
You will receive $100 after completing the medical exam.
Participants must be fasted prior to dosing.
Participants will remain seated for at least four hours after taking the medication.
Blood volume: Male 182ml / Female 182ml (23 blood draws per period). One overnight blood draw.
Your medical history and/or medication intake history may affect your participation on this study.
Please note that we are testing for drugs and alcohol during the medical evaluation.
This is preliminary information and changes could occur without notice